Please login to the form below

Not currently logged in
Email:
Password:

Storm Therapeutics

This page shows the latest Storm Therapeutics news and features for those working in and with pharma, biotech and healthcare.

RNA-focused biotech Storm Therapeutics raises extra £14m

RNA-focused biotech Storm Therapeutics raises extra £14m

New head of translational oncology also hired. Storm Therapeutics, the UK-based biotech specialising in modulating RNA modifying enzymes has announced that it has raised an extra £14m ($17.8m) from ... Keith Blundy. Dr Keith Blundy, chief executive of

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Professor Thomas Cech joins Storm Therapeutics Professor Thomas Cech joins Storm Therapeutics

    He takes up a scientific advisor role at the group. Storm Therapeutics, a company focused on the discovery of small molecule therapies has appointed Professor Thomas Cech as its scientific advisor. ... Commenting on the new appointments, Keith Blundy,

  • Storm Therapeutics bolsters its team Storm Therapeutics bolsters its team

    UK-based drug discovery group Storm Therapeutics has strengthened its scientific advisory board with the addition of Professor Mark Dawson. ... Keith Blundy, chief executive officer of Storm Therapeutics, said: “Mark’s expertise in epigenetics

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Professor Paul Workman joins as an independent director. Drug discovery group Storm Therapeutics has appointed Professor Paul Workman to join its board. ... UK. Keith Blundy, CEO, Storm Therapeutics, said: “I am pleased to welcome Paul as indepdent

More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics